FLUCONAZOLE

FLUCONAZOLE was reported 70760 times

FLUCONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 167 0.5512
1 DISSEMINATED MUCORMYCOSIS 74 0.1878
2 MENINGITIS CRYPTOCOCCAL 297 0.1697
3 CRYPTOCOCCOSIS 232 0.1422
4 FEMALE GENITAL TRACT FISTULA 236 0.1381
5 TEMPERATURE REGULATION DISORDER 274 0.1229
6 DISSEMINATED CRYPTOCOCCOSIS 86 0.1136
7 SKIN CANDIDA 59 0.1130
8 MUCORMYCOSIS 290 0.1115
9 ENGRAFTMENT SYNDROME 62 0.1049
10 IMMUNE RECONSTITUTION SYNDROME 131 0.1015
11 COCCIDIOIDOMYCOSIS 119 0.0997
12 FUNGAEMIA 152 0.0965
13 CEREBRAL TOXOPLASMOSIS 88 0.0942
14 SYSTEMIC MYCOSIS 108 0.0925
15 CANDIDA SEPSIS 81 0.0903
16 SINUSITIS FUNGAL 71 0.0885
17 PNEUMONIA CRYPTOCOCCAL 82 0.0868
18 SYSTEMIC CANDIDA 216 0.0860
19 ACINETOBACTER INFECTION 82 0.0749
20 FUNGAL SEPSIS 61 0.0734
21 APLASTIC ANAEMIA 380 0.0727
22 DYSBIOSIS 59 0.0719
23 RADICULOPATHY 189 0.0716
24 ENTEROCOCCAL SEPSIS 56 0.0691
25 ASPERGILLOSIS 90 0.0689
26 FOETAL DEATH 356 0.0686
27 PROCTITIS 187 0.0667
28 CHRONIC SINUSITIS 245 0.0652
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 68 0.0640
30 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 317 0.0636
31 ENTEROCOCCAL BACTERAEMIA 65 0.0613
32 TOXOPLASMOSIS 66 0.0611
33 OESOPHAGEAL CANDIDIASIS 239 0.0599
34 ORAL CANDIDIASIS 789 0.0599
35 VULVOVAGINAL CANDIDIASIS 80 0.0591
36 CANDIDIASIS 237 0.0590
37 STENOTROPHOMONAS INFECTION 79 0.0582
38 ENTEROCOCCAL INFECTION 280 0.0579
39 CANDIDA INFECTION 952 0.0563
40 GRAFT VERSUS HOST DISEASE 391 0.0543
41 FOOD ALLERGY 414 0.0536
42 HYPERPARATHYROIDISM SECONDARY 134 0.0534
43 NEPHROGENIC ANAEMIA 236 0.0509
44 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 107 0.0502
45 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 137 0.0495
46 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 163 0.0493
47 CYTOMEGALOVIRUS VIRAEMIA 211 0.0474
48 ASPERGILLUS INFECTION 309 0.0470
49 CYTOMEGALOVIRUS TEST POSITIVE 81 0.0454
50 GRAFT VERSUS HOST DISEASE IN SKIN 99 0.0449
51 ACUTE GRAFT VERSUS HOST DISEASE 202 0.0441
52 BRONCHOPULMONARY ASPERGILLOSIS 340 0.0438
53 CYTOMEGALOVIRUS CHORIORETINITIS 85 0.0435
54 ACUTE MYELOID LEUKAEMIA RECURRENT 90 0.0419
55 REBOUND ACID HYPERSECRETION 125 0.0413
56 FEBRILE NEUTROPENIA 2741 0.0413
57 PNEUMONIA FUNGAL 163 0.0413
58 ENTEROBACTER INFECTION 68 0.0404
59 BACTERIAL SEPSIS 131 0.0402
60 MUCOSAL INFLAMMATION 1035 0.0395
61 VENOOCCLUSIVE DISEASE 98 0.0391
62 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 55 0.0389
63 FIXED ERUPTION 66 0.0383
64 VENOOCCLUSIVE LIVER DISEASE 189 0.0382
65 PSEUDOMONAL SEPSIS 66 0.0376
66 KLEBSIELLA INFECTION 190 0.0375
67 PATHOGEN RESISTANCE 337 0.0369
68 CHRONIC GRAFT VERSUS HOST DISEASE 133 0.0368
69 APLASIA 70 0.0357
70 PSEUDOMEMBRANOUS COLITIS 78 0.0349
71 CYTOMEGALOVIRUS INFECTION REACTIVATION 154 0.0348
72 ORAL FUNGAL INFECTION 95 0.0347
73 IMMUNODEFICIENCY 516 0.0346
74 CYTOKINE RELEASE SYNDROME 694 0.0346
75 TOXIC EPIDERMAL NECROLYSIS 524 0.0345
76 PSEUDOMONAS INFECTION 295 0.0344
77 TORSADE DE POINTES 269 0.0343
78 CYSTITIS HAEMORRHAGIC 137 0.0340
79 CYTOMEGALOVIRUS INFECTION 557 0.0335
80 STAPHYLOCOCCAL BACTERAEMIA 143 0.0329
81 DIASTOLIC DYSFUNCTION 101 0.0327
82 FUNGAL INFECTION 1090 0.0327
83 CLOSTRIDIUM TEST POSITIVE 72 0.0326
84 MULTIPLE-DRUG RESISTANCE 99 0.0319
85 BILIARY DYSKINESIA 54 0.0318
86 SPUTUM INCREASED 68 0.0314
87 NOCARDIOSIS 80 0.0312
88 NEUTROPENIC SEPSIS 223 0.0312
89 STEM CELL TRANSPLANT 78 0.0312
90 NEUTROPENIC COLITIS 64 0.0309
91 BACTERAEMIA 353 0.0297
92 BLOOD CULTURE POSITIVE 89 0.0297
93 LONG QT SYNDROME 71 0.0296
94 MYCOBACTERIUM AVIUM COMPLEX INFECTION 78 0.0290
95 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 172 0.0290
96 PNEUMOCYSTIS JIROVECI PNEUMONIA 63 0.0283
97 VAGINAL INFECTION 132 0.0280
98 CLOSTRIDIUM DIFFICILE COLITIS 295 0.0278
99 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 106 0.0277
100 STAPHYLOCOCCAL SEPSIS 136 0.0275
101 ACUTE MYELOID LEUKAEMIA 425 0.0272
102 ATELECTASIS 263 0.0272
103 END STAGE RENAL DISEASE 493 0.0270
104 FUNGAL SKIN INFECTION 108 0.0267
105 EPSTEIN-BARR VIRUS INFECTION 167 0.0267
106 MULTI-ORGAN FAILURE 458 0.0265
107 TUMOUR LYSIS SYNDROME 233 0.0265
108 BRAIN ABSCESS 67 0.0265
109 CHOLECYSTITIS CHRONIC 177 0.0264
110 VULVOVAGINAL MYCOTIC INFECTION 103 0.0262
111 MULTIPLE ORGAN DYSFUNCTION SYNDROME 738 0.0260
112 VAGINAL DISCHARGE 262 0.0259
113 ADENOVIRUS INFECTION 74 0.0255
114 BK VIRUS INFECTION 85 0.0252
115 PANCYTOPENIA 1404 0.0251
116 ACUTE LYMPHOCYTIC LEUKAEMIA 71 0.0251
117 LIVER ABSCESS 81 0.0249
118 SEPTIC SHOCK 1076 0.0247
119 BLOOD CHLORIDE DECREASED 63 0.0244
120 RHINOVIRUS INFECTION 95 0.0244
121 COELIAC DISEASE 237 0.0241
122 BURSITIS 290 0.0239
123 ESCHERICHIA BACTERAEMIA 56 0.0238
124 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 62 0.0233
125 FAILURE TO THRIVE 121 0.0233
126 STEVENS-JOHNSON SYNDROME 515 0.0231
127 CUSHINGOID 74 0.0230
128 THROMBOPHLEBITIS SUPERFICIAL 69 0.0227
129 DISSEMINATED INTRAVASCULAR COAGULATION 319 0.0226
130 LUNG INFILTRATION 200 0.0226
131 CACHEXIA 116 0.0225
132 EMBOLISM VENOUS 68 0.0224
133 RESPIRATORY SYMPTOM 63 0.0221
134 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 166 0.0221
135 ESCHERICHIA SEPSIS 64 0.0221
136 DRUG RESISTANCE 567 0.0221
137 VASCULAR DEVICE INFECTION 100 0.0220
138 HYPOALBUMINAEMIA 171 0.0220
139 BLOOD LACTATE DEHYDROGENASE INCREASED 340 0.0214
140 CLOSTRIDIAL INFECTION 72 0.0213
141 ENCEPHALITIS 147 0.0212
142 LUNG CONSOLIDATION 59 0.0211
143 PRESCRIBED OVERDOSE 401 0.0207
144 ECONOMIC PROBLEM 312 0.0206
145 DRUG LEVEL INCREASED 339 0.0205
146 CHRONIC KIDNEY DISEASE 1546 0.0203
147 TRANSPLANT REJECTION 162 0.0202
148 HIV INFECTION 60 0.0199
149 HYPERBILIRUBINAEMIA 205 0.0198
150 ANHEDONIA 512 0.0195
151 DRUG INTERACTION 3089 0.0195
152 INTRACRANIAL PRESSURE INCREASED 108 0.0194
153 HYPOMAGNESAEMIA 267 0.0192
154 BONE LESION 69 0.0191
155 MULTIPLE MYELOMA 89 0.0191
156 NEUTROPHIL COUNT DECREASED 769 0.0188
157 ILEUS PARALYTIC 84 0.0188
158 THROMBOCYTOPENIA 2100 0.0188
159 ESCHERICHIA INFECTION 154 0.0187
160 HAEMODYNAMIC INSTABILITY 141 0.0185
161 ODYNOPHAGIA 109 0.0182
162 TRICUSPID VALVE INCOMPETENCE 145 0.0182
163 BONE MARROW FAILURE 368 0.0181
164 SEPSIS 2006 0.0180
165 ADRENAL INSUFFICIENCY 218 0.0179
166 NEPHROPATHY TOXIC 201 0.0179
167 BLOOD BILIRUBIN INCREASED 477 0.0176
168 SERUM FERRITIN INCREASED 93 0.0176
169 PULMONARY HAEMORRHAGE 137 0.0175
170 NEUROTOXICITY 305 0.0174
171 HYPOPHOSPHATAEMIA 127 0.0172
172 WOUND DEHISCENCE 58 0.0171
173 ORAL DISORDER 125 0.0170
174 HYPERURICAEMIA 70 0.0170
175 KIDNEY TRANSPLANT REJECTION 81 0.0169
176 LYMPHOCYTE COUNT DECREASED 298 0.0168
177 VULVOVAGINAL PRURITUS 85 0.0168
178 PATHOLOGICAL FRACTURE 85 0.0167
179 AGRANULOCYTOSIS 311 0.0167
180 PROTHROMBIN TIME PROLONGED 100 0.0167
181 RENAL TUBULAR NECROSIS 164 0.0167
182 BLOOD ALKALINE PHOSPHATASE INCREASED 413 0.0166
183 HYPOKALAEMIA 767 0.0166
184 UPPER RESPIRATORY TRACT INFECTION 764 0.0165
185 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 128 0.0165
186 STAPHYLOCOCCAL INFECTION 543 0.0164
187 PERIPHERAL SENSORY NEUROPATHY 96 0.0164
188 HYPERCALCAEMIA 201 0.0163
189 OESOPHAGITIS 177 0.0162
190 DIVERTICULUM 114 0.0160
191 LYMPHOPENIA 226 0.0160
192 RASH MACULO-PAPULAR 355 0.0159
193 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 81 0.0159
194 THROMBOTIC MICROANGIOPATHY 155 0.0159
195 ELECTROCARDIOGRAM QT PROLONGED 572 0.0159
196 HEPATOTOXICITY 354 0.0159
197 BLOOD ALBUMIN DECREASED 126 0.0159
198 PROTEIN TOTAL DECREASED 59 0.0157
199 DEVICE RELATED INFECTION 241 0.0156
200 MOUTH ULCERATION 329 0.0156
201 SPINAL OSTEOARTHRITIS 137 0.0156
202 ENTEROCOLITIS 90 0.0156
203 DERMATITIS BULLOUS 112 0.0155
204 CYTOPENIA 189 0.0154
205 RENAL FAILURE ACUTE 652 0.0153
206 ACUTE RESPIRATORY DISTRESS SYNDROME 270 0.0153
207 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 392 0.0152
208 HYPERLIPIDAEMIA 180 0.0150
209 RESPIRATORY FAILURE 1090 0.0149
210 DIFFUSE LARGE B-CELL LYMPHOMA 115 0.0149
211 HERPES SIMPLEX 97 0.0149
212 MENINGITIS 99 0.0148
213 OLIGURIA 92 0.0148
214 AZOTAEMIA 59 0.0148
215 PLATELET COUNT DECREASED 1561 0.0146
216 CHOLESTASIS 281 0.0146
217 STREPTOCOCCAL INFECTION 81 0.0145
218 ACUTE KIDNEY INJURY 2217 0.0145
219 COAGULOPATHY 241 0.0144
220 ACUTE RESPIRATORY FAILURE 278 0.0144
221 HEPATITIS CHOLESTATIC 87 0.0144
222 BACTERIAL INFECTION 269 0.0144
223 GAMMA-GLUTAMYLTRANSFERASE INCREASED 319 0.0144
224 INTERNATIONAL NORMALISED RATIO INCREASED 406 0.0142
225 C-REACTIVE PROTEIN INCREASED 518 0.0142
226 BLOOD UREA INCREASED 238 0.0142
227 LEUKOPENIA 710 0.0142
228 NEUTROPENIA 1924 0.0141
229 ECCHYMOSIS 97 0.0141
230 RENAL FAILURE 1876 0.0141
231 SHOCK HAEMORRHAGIC 115 0.0141
232 OSTEOPENIA 213 0.0140
233 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 124 0.0140
234 HYPOGAMMAGLOBULINAEMIA 92 0.0140
235 PULMONARY ALVEOLAR HAEMORRHAGE 78 0.0139
236 PURULENT DISCHARGE 59 0.0138
237 RENAL FAILURE CHRONIC 106 0.0138
238 ALANINE AMINOTRANSFERASE INCREASED 846 0.0138
239 HYPOXIA 485 0.0138
240 DRUG LEVEL ABOVE THERAPEUTIC 63 0.0137
241 ASPARTATE AMINOTRANSFERASE INCREASED 728 0.0137
242 HAEMODIALYSIS 115 0.0137
243 MYELODYSPLASTIC SYNDROME 198 0.0137
244 MALNUTRITION 153 0.0137
245 HYPERTRANSAMINASAEMIA 95 0.0136
246 PARAESTHESIA ORAL 197 0.0136
247 HYPERNATRAEMIA 68 0.0136
248 HEPATOMEGALY 134 0.0136
249 RASH ERYTHEMATOUS 649 0.0136
250 GENERALISED OEDEMA 168 0.0136
251 SKIN NECROSIS 70 0.0135
252 TACHYPNOEA 183 0.0134
253 INTERVERTEBRAL DISC DEGENERATION 124 0.0134
254 ENCEPHALOPATHY 329 0.0134
255 DERMATITIS EXFOLIATIVE 67 0.0134
256 ELECTROLYTE IMBALANCE 155 0.0133
257 NEUROLOGICAL SYMPTOM 76 0.0133
258 ERYTHEMA MULTIFORME 124 0.0133
259 VENTRICULAR TACHYCARDIA 218 0.0132
260 GINGIVITIS 70 0.0130
261 HIATUS HERNIA 167 0.0129
262 ANURIA 111 0.0129
263 LEFT VENTRICULAR HYPERTROPHY 55 0.0128
264 COLITIS 487 0.0128
265 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 65 0.0128
266 EMPHYSEMA 129 0.0128
267 EOSINOPHILIA 224 0.0128
268 MACULAR DEGENERATION 152 0.0127
269 TUBULOINTERSTITIAL NEPHRITIS 238 0.0127
270 PROCTALGIA 81 0.0126
271 DEEP VEIN THROMBOSIS 816 0.0125
272 INTESTINAL ISCHAEMIA 69 0.0125
273 BRAIN OEDEMA 158 0.0125
274 TRANSFUSION 131 0.0125
275 HEPATIC FAILURE 376 0.0125
276 HAEMATOCRIT DECREASED 247 0.0124
277 RALES 72 0.0124
278 PETECHIAE 129 0.0124
279 CHOLECYSTITIS ACUTE 70 0.0123
280 PLEURAL EFFUSION 750 0.0123
281 PYREXIA 4261 0.0123
282 HAEMATOTOXICITY 117 0.0123
283 PNEUMONIA BACTERIAL 113 0.0123
284 SUBCUTANEOUS ABSCESS 59 0.0123
285 DECUBITUS ULCER 100 0.0123
286 LEUKOCYTOSIS 222 0.0123
287 IRON DEFICIENCY ANAEMIA 113 0.0122
288 BUNDLE BRANCH BLOCK RIGHT 56 0.0122
289 RENAL INJURY 361 0.0121
290 TOXIC SKIN ERUPTION 122 0.0121
291 LARGE INTESTINE PERFORATION 84 0.0121
292 ABDOMINAL TENDERNESS 60 0.0121
293 CHRONIC LYMPHOCYTIC LEUKAEMIA 57 0.0120
294 HYPERKALAEMIA 421 0.0120
295 TOOTH ABSCESS 122 0.0120
296 BREATH SOUNDS ABNORMAL 59 0.0120
297 BLOOD LACTIC ACID INCREASED 63 0.0119
298 HEPATIC FUNCTION ABNORMAL 446 0.0119
299 HYDROCEPHALUS 65 0.0119
300 MENTAL STATUS CHANGES 331 0.0119
301 ILEUS 148 0.0119
302 LIPASE INCREASED 91 0.0119
303 NECROSIS 66 0.0118
304 HEPATIC ENZYME INCREASED 804 0.0118
305 INFUSION RELATED REACTION 779 0.0117
306 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 112 0.0117
307 BLOOD PRESSURE DIASTOLIC INCREASED 54 0.0117
308 PNEUMOTHORAX 185 0.0117
309 BLOOD URIC ACID INCREASED 67 0.0116
310 NASAL POLYPS 57 0.0116
311 DRUG-INDUCED LIVER INJURY 361 0.0115
312 SWOLLEN TONGUE 359 0.0115
313 SUPRAVENTRICULAR TACHYCARDIA 110 0.0115
314 HYPONATRAEMIA 647 0.0115
315 HYPOVOLAEMIA 67 0.0114
316 METABOLIC ACIDOSIS 366 0.0114
317 DRUG ERUPTION 202 0.0114
318 ACIDOSIS 87 0.0114
319 CLOSTRIDIUM DIFFICILE INFECTION 248 0.0114
320 BLOOD MAGNESIUM DECREASED 98 0.0113
321 BLOOD CREATININE INCREASED 740 0.0113
322 ORGANISING PNEUMONIA 56 0.0113
323 PNEUMONITIS 307 0.0113
324 ANAEMIA 2144 0.0112
325 HEPATIC ENZYME ABNORMAL 56 0.0112
326 PNEUMOCYSTIS JIROVECII PNEUMONIA 112 0.0111
327 WHITE BLOOD CELL COUNT DECREASED 1208 0.0111
328 LUNG INFECTION 173 0.0111
329 MITRAL VALVE INCOMPETENCE 126 0.0111
330 DIABETIC NEUROPATHY 55 0.0111
331 ABSCESS 177 0.0111
332 DRUG TOXICITY 151 0.0111
333 CONTRAINDICATED PRODUCT ADMINISTERED 335 0.0111
334 SKIN LESION 303 0.0110
335 RENAL IMPAIRMENT 923 0.0110
336 PHARYNGITIS 136 0.0110
337 CARDIAC FAILURE ACUTE 73 0.0109
338 STOMATITIS 664 0.0109
339 ENTERITIS 70 0.0109
340 SINUS TACHYCARDIA 155 0.0109
341 PRE-EXISTING CONDITION IMPROVED 68 0.0109
342 VITAMIN D DEFICIENCY 106 0.0109
343 DYSLIPIDAEMIA 55 0.0108
344 EXPOSURE DURING PREGNANCY 670 0.0108
345 ASCITES 316 0.0107
346 PHLEBITIS 55 0.0107
347 UROSEPSIS 99 0.0107
348 INFECTION 1543 0.0106
349 SPINAL COMPRESSION FRACTURE 88 0.0106
350 HEPATITIS ACUTE 69 0.0106
351 RESPIRATORY DISTRESS 291 0.0105
352 HERPES VIRUS INFECTION 60 0.0104
353 SPLENOMEGALY 122 0.0104
354 CARDIOMEGALY 128 0.0104
355 ATRIAL FLUTTER 83 0.0104
356 NEPHROPATHY 97 0.0104
357 ORAL PAIN 232 0.0104
358 CHEILITIS 56 0.0103
359 BLOOD SODIUM DECREASED 195 0.0103
360 RESPIRATORY SYNCYTIAL VIRUS INFECTION 90 0.0103
361 OSTEOPOROSIS 425 0.0103
362 JAUNDICE 278 0.0103
363 OSTEOMYELITIS 186 0.0103
364 HAEMOLYTIC ANAEMIA 92 0.0103
365 HAEMOLYSIS 79 0.0102
366 HOSPICE CARE 101 0.0102
367 SHOCK 233 0.0101
368 HYPERTRIGLYCERIDAEMIA 59 0.0101
369 MULTIPLE ALLERGIES 79 0.0101
370 TRANSAMINASES INCREASED 223 0.0100
371 LEFT VENTRICULAR DYSFUNCTION 67 0.0100
372 IMMUNOSUPPRESSION 88 0.0100
373 PSYCHOLOGICAL TRAUMA 86 0.0100
374 VASCULITIS 116 0.0099
375 PULMONARY MASS 148 0.0099
376 LIVER FUNCTION TEST ABNORMAL 288 0.0099
377 SKIN INFECTION 111 0.0099
378 GALLBLADDER DISORDER 176 0.0099
379 HYPERGLYCAEMIA 359 0.0098
380 PURPURA 87 0.0098
381 CHOLECYSTITIS 117 0.0098
382 FLANK PAIN 92 0.0098
383 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 538 0.0098
384 IMPAIRED GASTRIC EMPTYING 133 0.0097
385 VULVOVAGINAL BURNING SENSATION 59 0.0097
386 FLUID RETENTION 490 0.0096
387 PANCREATITIS ACUTE 216 0.0096
388 SLEEP APNOEA SYNDROME 183 0.0096
389 HEPATIC CYTOLYSIS 122 0.0096
390 BONE DISORDER 174 0.0095
391 URINE OUTPUT DECREASED 83 0.0095
392 CHOLELITHIASIS 310 0.0094
393 PLASMA CELL MYELOMA 367 0.0094
394 STATUS EPILEPTICUS 106 0.0094
395 DECREASED IMMUNE RESPONSIVENESS 92 0.0094
396 DELIRIUM 325 0.0094
397 OBSTRUCTIVE AIRWAYS DISORDER 104 0.0093
398 BLOOD CALCIUM DECREASED 105 0.0093
399 CELLULITIS 469 0.0093
400 HAEMOGLOBIN DECREASED 953 0.0093
401 FULL BLOOD COUNT DECREASED 187 0.0093
402 PULMONARY EMBOLISM 881 0.0093
403 GASTROENTERITIS 134 0.0092
404 VENTRICULAR EXTRASYSTOLES 95 0.0091
405 TENDERNESS 95 0.0091
406 LEUKAEMIA 86 0.0091
407 VENTRICULAR FIBRILLATION 101 0.0091
408 HYDRONEPHROSIS 68 0.0091
409 RECTAL HAEMORRHAGE 390 0.0091
410 ACUTE HEPATIC FAILURE 124 0.0091
411 PNEUMONIA 2937 0.0091
412 INFUSION SITE SWELLING 57 0.0090
413 HYPOCALCAEMIA 171 0.0090
414 MYOPATHY 78 0.0090
415 UTERINE PERFORATION 76 0.0090
416 COVID-19 PNEUMONIA 106 0.0090
417 SEASONAL ALLERGY 127 0.0090
418 HEPATOCELLULAR INJURY 127 0.0089
419 ASPIRATION 98 0.0089
420 MULTIPLE FRACTURES 145 0.0088
421 IMPAIRED QUALITY OF LIFE 126 0.0088
422 ARTERIOSCLEROSIS CORONARY ARTERY 58 0.0087
423 LYMPHADENOPATHY 309 0.0087
424 RHABDOMYOLYSIS 364 0.0087
425 BLOOD POTASSIUM DECREASED 262 0.0087
426 RENAL CYST 69 0.0087
427 SINUSITIS 887 0.0086
428 INJURY 608 0.0086
429 TOOTH INFECTION 114 0.0086
430 SEROTONIN SYNDROME 165 0.0086
431 POSTOPERATIVE WOUND INFECTION 58 0.0086
432 GASTRITIS 225 0.0085
433 HAEMOPTYSIS 238 0.0085
434 HICCUPS 70 0.0085
435 FREQUENT BOWEL MOVEMENTS 230 0.0085
436 PNEUMONIA ASPIRATION 211 0.0084
437 DERMATITIS CONTACT 96 0.0084
438 DYSPHAGIA 798 0.0084
439 FACIAL PAIN 75 0.0084
440 SKIN HYPERPIGMENTATION 72 0.0084
441 LOWER RESPIRATORY TRACT INFECTION 381 0.0084
442 RASH PUSTULAR 61 0.0084
443 HYPOPHAGIA 214 0.0084
444 WHITE BLOOD CELL COUNT INCREASED 320 0.0083
445 GRAND MAL CONVULSION 77 0.0083
446 CYSTITIS 265 0.0083
447 DRUG INTOLERANCE 803 0.0083
448 RED BLOOD CELL COUNT DECREASED 237 0.0083
449 INTESTINAL PERFORATION 93 0.0083
450 NEUROPATHY PERIPHERAL 785 0.0082
451 DEHYDRATION 1100 0.0082
452 LIVER DISORDER 364 0.0082
453 MYELOSUPPRESSION 295 0.0082
454 BODY TEMPERATURE INCREASED 167 0.0082
455 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 84 0.0082
456 BRONCHIECTASIS 55 0.0082
457 EOSINOPHIL COUNT INCREASED 68 0.0082
458 BLOOD PRESSURE DIASTOLIC DECREASED 60 0.0081
459 NERVOUS SYSTEM DISORDER 252 0.0081
460 TREATMENT FAILURE 667 0.0080
461 FLUID OVERLOAD 117 0.0080
462 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 66 0.0080
463 OEDEMA 434 0.0080
464 ARTERIOSCLEROSIS 75 0.0080
465 PERICARDIAL EFFUSION 184 0.0080
466 INFUSION SITE ERYTHEMA 67 0.0079
467 ALTERED STATE OF CONSCIOUSNESS 172 0.0079
468 FOOT FRACTURE 150 0.0079
469 MOUTH HAEMORRHAGE 58 0.0079
470 RESPIRATORY TRACT INFECTION 206 0.0079
471 URINARY TRACT INFECTION 1348 0.0079
472 HAEMATURIA 270 0.0079
473 TONGUE DISORDER 57 0.0079
474 PULMONARY OEDEMA 352 0.0079
475 CARDIAC MURMUR 68 0.0079
476 HYSTERECTOMY 68 0.0078
477 RESPIRATORY DEPRESSION 96 0.0078
478 BLOOD POTASSIUM INCREASED 127 0.0078
479 DYSPHONIA 457 0.0078
480 CONSTIPATION 1704 0.0078
481 SINUS BRADYCARDIA 75 0.0078
482 ATAXIA 92 0.0077
483 HAEMORRHOIDS 151 0.0077
484 LIVER INJURY 190 0.0077
485 ACUTE CORONARY SYNDROME 64 0.0077
486 EJECTION FRACTION DECREASED 120 0.0077
487 MYOCLONUS 92 0.0077
488 HEPATITIS 197 0.0077
489 PRODUCT ADMINISTRATION INTERRUPTED 60 0.0076
490 OSTEOARTHRITIS 324 0.0076
491 DERMATITIS 160 0.0076
492 ORAL HERPES 149 0.0076
493 BODY TEMPERATURE DECREASED 75 0.0076
494 PYELONEPHRITIS 66 0.0076
495 SWELLING FACE 495 0.0076
496 DENTAL CARIES 84 0.0076
497 TACHYCARDIA 670 0.0075
498 HEPATIC STEATOSIS 140 0.0075
499 EAR PAIN 146 0.0075
500 PULMONARY CONGESTION 99 0.0075
501 LYMPHOMA 116 0.0075
502 MUSCULOSKELETAL CHEST PAIN 116 0.0075
503 PHARYNGEAL SWELLING 73 0.0075
504 HEMIPARESIS 126 0.0074
505 ATRIAL FIBRILLATION 724 0.0074
506 NEUTROPHIL COUNT INCREASED 76 0.0074
507 PULMONARY HYPERTENSION 154 0.0074
508 PERITONITIS 153 0.0074
509 UPPER GASTROINTESTINAL HAEMORRHAGE 124 0.0074
510 CARDIAC ARREST 608 0.0074
511 DYSPNOEA EXERTIONAL 277 0.0073
512 DEPRESSED LEVEL OF CONSCIOUSNESS 290 0.0073
513 URINARY INCONTINENCE 217 0.0073
514 ANGIOEDEMA 324 0.0073
515 MELAENA 161 0.0073
516 CARDIOTOXICITY 65 0.0073
517 CONJUNCTIVITIS 135 0.0073
518 ASTHMA 822 0.0073
519 OEDEMA PERIPHERAL 884 0.0072
520 ORTHOSTATIC HYPOTENSION 126 0.0072
521 HAEMATOMA 187 0.0072
522 HYPOTONIA 72 0.0072
523 DISEASE PROGRESSION 852 0.0072
524 CEREBRAL INFARCTION 175 0.0072
525 HAIR DISORDER 59 0.0072
526 SCIATICA 114 0.0071
527 ANOREXIA 92 0.0071
528 HAEMATOCHEZIA 394 0.0071
529 GENERALISED TONIC-CLONIC SEIZURE 118 0.0071
530 GASTROOESOPHAGEAL REFLUX DISEASE 574 0.0071
531 DYSURIA 262 0.0071
532 ABDOMINAL PAIN 1632 0.0070
533 HYPOTENSION 1405 0.0070
534 POLYURIA 57 0.0070
535 RHINITIS 56 0.0069
536 NERVE INJURY 77 0.0069
537 BLOOD DISORDER 55 0.0069
538 QUALITY OF LIFE DECREASED 92 0.0069
539 SPUTUM DISCOLOURED 65 0.0068
540 ROTATOR CUFF SYNDROME 88 0.0068
541 BRONCHITIS 507 0.0068
542 BLISTER 384 0.0068
543 DIALYSIS 97 0.0068
544 CHOLECYSTECTOMY 78 0.0068
545 SKIN LACERATION 74 0.0068
546 FACIAL PARALYSIS 58 0.0068
547 TOOTHACHE 123 0.0068
548 BLOOD TRIGLYCERIDES INCREASED 120 0.0068
549 EMBOLISM 56 0.0067
550 SKIN ULCER 174 0.0067
551 SUBDURAL HAEMATOMA 96 0.0067
552 PANCREATITIS 354 0.0067
553 LIP SWELLING 223 0.0067
554 UPPER-AIRWAY COUGH SYNDROME 55 0.0067
555 VIRAL INFECTION 221 0.0066
556 DEFORMITY 62 0.0066
557 THERAPY NON-RESPONDER 298 0.0066
558 HEMIPLEGIA 55 0.0066
559 ABNORMAL FAECES 54 0.0066
560 SMALL INTESTINAL OBSTRUCTION 81 0.0066
561 CENTRAL NERVOUS SYSTEM LESION 90 0.0065
562 CARDIAC FAILURE 525 0.0065
563 HYPERCHOLESTEROLAEMIA 63 0.0065
564 PROCEDURAL PAIN 181 0.0065
565 BRONCHOSPASM 93 0.0065
566 RIB FRACTURE 134 0.0065
567 HERPES ZOSTER 374 0.0065
568 DIVERTICULITIS 180 0.0065
569 FISTULA 73 0.0065
570 CARDIOGENIC SHOCK 93 0.0065
571 SUBARACHNOID HAEMORRHAGE 66 0.0065
572 FACE OEDEMA 109 0.0065
573 EXOSTOSIS 59 0.0065
574 PRODUCTIVE COUGH 308 0.0064
575 BONE DENSITY DECREASED 202 0.0064
576 UNRESPONSIVE TO STIMULI 166 0.0064
577 CARDIOMYOPATHY 95 0.0064
578 NEURALGIA 156 0.0064
579 LACERATION 60 0.0064
580 IMMUNE SYSTEM DISORDER 84 0.0064
581 GASTROINTESTINAL INFECTION 57 0.0064
582 EMOTIONAL DISTRESS 768 0.0063
583 HYPERSENSITIVITY 1175 0.0063
584 HEPATIC ENCEPHALOPATHY 59 0.0063
585 RESPIRATORY DISORDER 189 0.0063
586 SCAR 108 0.0063
587 EPISTAXIS 471 0.0063
588 HYPERTENSION 1331 0.0063
589 MYOSITIS 56 0.0062
590 SINUS DISORDER 123 0.0062
591 ABORTION SPONTANEOUS 248 0.0062
592 SKIN REACTION 87 0.0062
593 CIRCULATORY COLLAPSE 105 0.0062
594 RASH GENERALISED 159 0.0061
595 DYSPEPSIA 604 0.0061
596 INTERVERTEBRAL DISC PROTRUSION 134 0.0061
597 WOUND INFECTION 67 0.0061
598 JOINT RANGE OF MOTION DECREASED 82 0.0061
599 FOLLICULITIS 64 0.0061
600 INCREASED TENDENCY TO BRUISE 56 0.0061
601 HAEMORRHAGE INTRACRANIAL 91 0.0061
602 GASTROINTESTINAL HAEMORRHAGE 508 0.0061
603 GENERAL PHYSICAL HEALTH DETERIORATION 703 0.0061
604 PERITONITIS BACTERIAL 61 0.0060
605 EAR INFECTION 159 0.0060
606 RED BLOOD CELL SEDIMENTATION RATE INCREASED 66 0.0060
607 GASTRIC ULCER 113 0.0059
608 ABDOMINAL PAIN LOWER 150 0.0059
609 CHILLS 695 0.0059
610 OXYGEN SATURATION DECREASED 333 0.0059
611 RENAL DISORDER 276 0.0059
612 HAEMATEMESIS 150 0.0059
613 OBESITY 94 0.0059
614 OROPHARYNGEAL PAIN 546 0.0059
615 DISEASE RECURRENCE 280 0.0059
616 COLITIS ULCERATIVE 263 0.0059
617 GLOMERULAR FILTRATION RATE DECREASED 72 0.0059
618 MADAROSIS 68 0.0059
619 JOINT SWELLING 707 0.0059
620 DECREASED ACTIVITY 63 0.0058
621 CEREBRAL HAEMORRHAGE 209 0.0058
622 BACK PAIN 1355 0.0058
623 PLATELET COUNT INCREASED 76 0.0058
624 ARRHYTHMIA 276 0.0058
625 NO THERAPEUTIC RESPONSE 71 0.0058
626 PHARYNGITIS STREPTOCOCCAL 63 0.0058
627 ERYTHEMA 1194 0.0058
628 HYPERHIDROSIS 746 0.0058
629 RASH 2522 0.0058
630 GLAUCOMA 111 0.0058
631 POLYNEUROPATHY 69 0.0058
632 INFUSION SITE PAIN 74 0.0057
633 CYANOSIS 90 0.0057
634 CONFUSIONAL STATE 924 0.0057
635 CORONARY ARTERY DISEASE 173 0.0057
636 DECREASED APPETITE 1325 0.0057
637 HYPOTHYROIDISM 182 0.0057
638 SKIN DISORDER 189 0.0057
639 APHASIA 171 0.0057
640 DIARRHOEA 3655 0.0057
641 BLOOD PRESSURE SYSTOLIC INCREASED 110 0.0056
642 LOCALISED INFECTION 136 0.0056
643 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 131 0.0056
644 ORAL DISCOMFORT 78 0.0056
645 HAIR TEXTURE ABNORMAL 75 0.0056
646 KIDNEY INFECTION 110 0.0056
647 LETHARGY 322 0.0056
648 LACTIC ACIDOSIS 181 0.0056
649 DIABETES MELLITUS 425 0.0056
650 HALLUCINATION, VISUAL 117 0.0055
651 INTENTIONAL PRODUCT MISUSE 485 0.0055
652 MASS 77 0.0055
653 CONVULSION 315 0.0055
654 CARDIO-RESPIRATORY ARREST 230 0.0055
655 OSTEONECROSIS OF JAW 136 0.0055
656 ANKLE FRACTURE 85 0.0055
657 ANXIETY 1562 0.0055
658 BRADYCARDIA 288 0.0054
659 PROTEINURIA 103 0.0054
660 PHARYNGEAL OEDEMA 83 0.0054
661 INTERSTITIAL LUNG DISEASE 261 0.0054
662 SUDDEN DEATH 57 0.0054
663 OFF LABEL USE 4705 0.0054
664 TOOTH FRACTURE 59 0.0053
665 RETCHING 114 0.0053
666 CYST 66 0.0053
667 WEIGHT DECREASED 1477 0.0053
668 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 276 0.0053
669 CONDITION AGGRAVATED 1605 0.0053
670 PHOTOSENSITIVITY REACTION 87 0.0053
671 PAIN 3210 0.0052
672 GINGIVAL BLEEDING 71 0.0052
673 VOMITING 2440 0.0052
674 SINUS CONGESTION 70 0.0052
675 NEPHROLITHIASIS 237 0.0052
676 NECK PAIN 287 0.0051
677 NODULE 67 0.0051
678 BONE PAIN 300 0.0051
679 FAECES DISCOLOURED 111 0.0051
680 HYPOGLYCAEMIA 247 0.0051
681 PAIN IN JAW 144 0.0051
682 MICTURITION URGENCY 58 0.0051
683 PELVIC PAIN 92 0.0051
684 BONE LOSS 76 0.0051
685 TENDONITIS 78 0.0050
686 MYOCARDIAL ISCHAEMIA 57 0.0050
687 DIPLOPIA 130 0.0050
688 RHEUMATOID ARTHRITIS 567 0.0050
689 OSTEONECROSIS 164 0.0050
690 NEUROLEPTIC MALIGNANT SYNDROME 59 0.0050
691 PRODUCT USE ISSUE 932 0.0050
692 SECRETION DISCHARGE 62 0.0049
693 PRODUCT USE IN UNAPPROVED INDICATION 1224 0.0049
694 DERMATITIS ALLERGIC 62 0.0049
695 POLLAKIURIA 205 0.0049
696 WHEEZING 291 0.0049
697 IMPAIRED HEALING 161 0.0049
698 HAIR COLOUR CHANGES 61 0.0049
699 NAUSEA 3868 0.0049
700 ISCHAEMIC STROKE 87 0.0049
701 ASTHENIA 1832 0.0049
702 SYNCOPE 486 0.0049
703 CHEST PAIN 899 0.0048
704 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 82 0.0048
705 URINARY RETENTION 161 0.0048
706 MUSCLE ATROPHY 61 0.0048
707 DEPRESSION 1094 0.0048
708 MUSCULAR WEAKNESS 546 0.0048
709 CARPAL TUNNEL SYNDROME 67 0.0048
710 HEADACHE 2999 0.0048
711 FIBROMYALGIA 116 0.0048
712 GASTROENTERITIS VIRAL 86 0.0048
713 DIABETES MELLITUS INADEQUATE CONTROL 84 0.0047
714 FEEDING DISORDER 96 0.0047
715 TOOTH LOSS 98 0.0047
716 MUSCULOSKELETAL PAIN 246 0.0047
717 BLOOD URINE PRESENT 89 0.0047
718 HAEMORRHAGE 489 0.0047
719 NEOPLASM PROGRESSION 162 0.0047
720 LIVER FUNCTION TEST INCREASED 100 0.0047
721 HALLUCINATION 350 0.0046
722 LABORATORY TEST ABNORMAL 137 0.0046
723 COMA 220 0.0046
724 NOCTURIA 56 0.0046
725 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 327 0.0046
726 LUNG DISORDER 225 0.0046
727 BLOOD PRESSURE DECREASED 305 0.0046
728 HYPOAESTHESIA 687 0.0046
729 ABDOMINAL DISTENSION 478 0.0046
730 HYPOAESTHESIA ORAL 69 0.0046
731 COUGH 1283 0.0046
732 INFLAMMATION 236 0.0046
733 IRRITABLE BOWEL SYNDROME 98 0.0046
734 RASH PAPULAR 102 0.0045
735 RASH PRURITIC 246 0.0045
736 POST PROCEDURAL COMPLICATION 87 0.0045
737 ULCER 72 0.0045
738 THROMBOSIS 362 0.0045
739 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 215 0.0045
740 DEAFNESS 117 0.0045
741 PHOTOPHOBIA 84 0.0045
742 DYSARTHRIA 168 0.0045
743 LIMB INJURY 121 0.0045
744 DIABETIC KETOACIDOSIS 107 0.0044
745 DYSPNOEA 2504 0.0044
746 BLOOD COUNT ABNORMAL 67 0.0044
747 GASTROINTESTINAL DISORDER 392 0.0044
748 ECZEMA 228 0.0044
749 DISORIENTATION 171 0.0043
750 CHROMATURIA 97 0.0043
751 CARDIAC FAILURE CONGESTIVE 345 0.0043
752 CONTUSION 412 0.0043
753 SKIN EXFOLIATION 361 0.0043
754 FATIGUE 3320 0.0043
755 SWELLING 398 0.0042
756 INTESTINAL OBSTRUCTION 160 0.0042
757 RASH MACULAR 148 0.0042
758 THERAPY PARTIAL RESPONDER 66 0.0042
759 TOOTH DISORDER 94 0.0042
760 TYPE 2 DIABETES MELLITUS 142 0.0042
761 CATARACT 251 0.0042
762 BACK DISORDER 68 0.0042
763 CHEST DISCOMFORT 426 0.0042
764 EPILEPSY 127 0.0042
765 PERIPHERAL COLDNESS 57 0.0041
766 EATING DISORDER 88 0.0041
767 INFLUENZA 459 0.0041
768 ARTHRITIS 323 0.0041
769 BLOOD CHOLESTEROL INCREASED 191 0.0041
770 TASTE DISORDER 83 0.0041
771 PSORIASIS 533 0.0041
772 DYSSTASIA 119 0.0041
773 UVEITIS 55 0.0041
774 INSURANCE ISSUE 62 0.0041
775 TREATMENT NONCOMPLIANCE 221 0.0040
776 TRANSIENT ISCHAEMIC ATTACK 136 0.0040
777 DRY MOUTH 326 0.0040
778 COORDINATION ABNORMAL 56 0.0040
779 MUSCLE TIGHTNESS 65 0.0040
780 NIGHT SWEATS 129 0.0040
781 DISCOMFORT 244 0.0040
782 DRUG INEFFECTIVE 5269 0.0040
783 SPINAL FRACTURE 80 0.0040
784 PRESYNCOPE 97 0.0040
785 PREMATURE BABY 120 0.0040
786 HEART RATE INCREASED 394 0.0040
787 PULMONARY FIBROSIS 76 0.0040
788 BRAIN FOG 62 0.0040
789 LOSS OF CONSCIOUSNESS 506 0.0039
790 ANAPHYLACTIC REACTION 218 0.0039
791 BLOOD CREATINE PHOSPHOKINASE INCREASED 113 0.0039
792 PRESCRIBED UNDERDOSE 78 0.0039
793 RESTLESS LEGS SYNDROME 71 0.0039
794 GOUT 70 0.0039
795 ACUTE MYOCARDIAL INFARCTION 115 0.0039
796 BALANCE DISORDER 336 0.0039
797 PRURITUS GENERALISED 84 0.0039
798 TREMOR 644 0.0039
799 HERNIA 75 0.0039
800 THIRST 69 0.0039
801 HEART RATE DECREASED 135 0.0038
802 LOCAL SWELLING 67 0.0038
803 METASTASES TO BONE 63 0.0038
804 MENTAL DISORDER 167 0.0038
805 ABDOMINAL PAIN UPPER 788 0.0038
806 COGNITIVE DISORDER 178 0.0038
807 SENSORY DISTURBANCE 61 0.0038
808 ACTIVITIES OF DAILY LIVING IMPAIRED 75 0.0038
809 SKIN DISCOLOURATION 173 0.0038
810 FEAR 101 0.0038
811 BLOOD PRESSURE FLUCTUATION 90 0.0037
812 PALLOR 102 0.0037
813 EYE SWELLING 139 0.0037
814 PALPITATIONS 437 0.0037
815 BLOOD PRESSURE INCREASED 569 0.0037
816 HEART RATE IRREGULAR 84 0.0037
817 MUSCLE SPASMS 682 0.0037
818 RESPIRATORY TRACT CONGESTION 59 0.0037
819 MALIGNANT NEOPLASM PROGRESSION 377 0.0037
820 MENTAL IMPAIRMENT 89 0.0037
821 ALOPECIA 721 0.0037
822 EYE PAIN 207 0.0037
823 UPPER LIMB FRACTURE 73 0.0037
824 PAIN IN EXTREMITY 1079 0.0037
825 MUSCULOSKELETAL DISCOMFORT 63 0.0037
826 BASAL CELL CARCINOMA 57 0.0036
827 MYALGIA 621 0.0036
828 URTICARIA 609 0.0036
829 HYPERSOMNIA 104 0.0036
830 RESPIRATORY ARREST 100 0.0036
831 NASAL CONGESTION 213 0.0036
832 BURNING SENSATION 254 0.0036
833 TOXICITY TO VARIOUS AGENTS 610 0.0036
834 MIGRAINE 345 0.0036
835 JOINT INJURY 77 0.0036
836 INTENTIONAL PRODUCT USE ISSUE 314 0.0036
837 FLATULENCE 203 0.0036
838 WOUND 100 0.0036
839 PERICARDITIS 60 0.0036
840 COVID-19 624 0.0036
841 WEIGHT INCREASED 795 0.0035
842 HIP FRACTURE 114 0.0035
843 SOMNOLENCE 712 0.0035
844 AMNESIA 230 0.0035
845 PARAESTHESIA 556 0.0035
846 MALAISE 1547 0.0035
847 PERIPHERAL SWELLING 543 0.0035
848 TINNITUS 161 0.0035
849 PRURITUS 1344 0.0035
850 SEIZURE 403 0.0035
851 ABASIA 86 0.0035
852 METASTASES TO LIVER 61 0.0035
853 GAIT DISTURBANCE 663 0.0035
854 AGITATION 253 0.0034
855 POOR QUALITY SLEEP 74 0.0034
856 FALL 1140 0.0034
857 PARANOIA 59 0.0034
858 PANIC ATTACK 124 0.0034
859 DISABILITY 67 0.0034
860 THROAT TIGHTNESS 91 0.0034
861 VAGINAL HAEMORRHAGE 146 0.0034
862 PRODUCT PRESCRIBING ISSUE 73 0.0033
863 GLOSSODYNIA 75 0.0033
864 HEAD INJURY 106 0.0033
865 ARTHROPATHY 186 0.0033
866 ARTHRALGIA 1390 0.0033
867 MOBILITY DECREASED 240 0.0033
868 SPEECH DISORDER 175 0.0033
869 BLOOD PRESSURE ABNORMAL 66 0.0033
870 ILLNESS 340 0.0033
871 DYSKINESIA 134 0.0033
872 SYNOVITIS 59 0.0033
873 RHINORRHOEA 211 0.0033
874 EYE DISORDER 107 0.0033
875 MUSCLE TWITCHING 75 0.0033
876 DIZZINESS 1604 0.0032
877 VERTIGO 196 0.0032
878 ANGINA PECTORIS 92 0.0032
879 DYSGEUSIA 236 0.0032
880 MATERNAL EXPOSURE DURING PREGNANCY 281 0.0031
881 NASOPHARYNGITIS 578 0.0031
882 SEDATION 82 0.0031
883 SURGERY 183 0.0031
884 SNEEZING 70 0.0031
885 TARDIVE DYSKINESIA 88 0.0031
886 MUSCULOSKELETAL STIFFNESS 273 0.0031
887 INSOMNIA 830 0.0031
888 UNEVALUABLE EVENT 235 0.0031
889 LACRIMATION INCREASED 93 0.0031
890 SYSTEMIC LUPUS ERYTHEMATOSUS 109 0.0031
891 JOINT STIFFNESS 80 0.0030
892 DRY EYE 152 0.0030
893 IMPAIRED WORK ABILITY 65 0.0030
894 OCULAR HYPERAEMIA 144 0.0030
895 SLEEP DISORDER 214 0.0030
896 ABDOMINAL DISCOMFORT 493 0.0029
897 VISION BLURRED 403 0.0029
898 OVERDOSE 630 0.0029
899 DISTURBANCE IN ATTENTION 157 0.0029
900 FRACTURE 55 0.0029
901 THROAT IRRITATION 130 0.0029
902 PRODUCT DOSE OMISSION IN ERROR 82 0.0029
903 FEELING JITTERY 55 0.0029
904 PSYCHOTIC DISORDER 85 0.0029
905 INTENTIONAL DOSE OMISSION 82 0.0029
906 DEPRESSED MOOD 152 0.0029
907 FEELING COLD 79 0.0028
908 PSORIATIC ARTHROPATHY 114 0.0028
909 GASTRIC DISORDER 96 0.0028
910 BLINDNESS 113 0.0028
911 LIMB DISCOMFORT 85 0.0027
912 ROAD TRAFFIC ACCIDENT 114 0.0027
913 MOVEMENT DISORDER 87 0.0027
914 ABNORMAL BEHAVIOUR 107 0.0027
915 ILL-DEFINED DISORDER 164 0.0027
916 INFLUENZA LIKE ILLNESS 220 0.0027
917 THERAPEUTIC RESPONSE UNEXPECTED 119 0.0026
918 FEMUR FRACTURE 82 0.0026
919 DERMATITIS ATOPIC 139 0.0026
920 MEMORY IMPAIRMENT 359 0.0026
921 AGEUSIA 65 0.0026
922 HOSPITALISATION 400 0.0026
923 MOOD ALTERED 71 0.0026
924 EMOTIONAL DISORDER 80 0.0026
925 DEATH 2217 0.0026
926 DRUG EXPOSURE DURING PREGNANCY 85 0.0025
927 VISUAL IMPAIRMENT 309 0.0025
928 THERAPY INTERRUPTED 178 0.0025
929 RESTLESSNESS 91 0.0025
930 CEREBROVASCULAR ACCIDENT 421 0.0025
931 HYPOACUSIS 105 0.0024
932 CARDIAC DISORDER 228 0.0024
933 FOETAL EXPOSURE DURING PREGNANCY 198 0.0024
934 FEELING HOT 149 0.0024
935 MOOD SWINGS 77 0.0024
936 SUICIDAL IDEATION 221 0.0024
937 NERVOUSNESS 125 0.0024
938 EXTRAPYRAMIDAL DISORDER 59 0.0024
939 PRODUCT DOSE OMISSION ISSUE 694 0.0024
940 EYE PRURITUS 79 0.0023
941 VISUAL ACUITY REDUCED 77 0.0023
942 FEELING ABNORMAL 554 0.0023
943 MYOCARDIAL INFARCTION 400 0.0023
944 NEOPLASM MALIGNANT 153 0.0023
945 PRODUCT DOSE OMISSION 149 0.0023
946 THERAPEUTIC RESPONSE DECREASED 138 0.0023
947 BLOOD GLUCOSE DECREASED 109 0.0023
948 CARDIOVASCULAR DISORDER 57 0.0022
949 PAIN OF SKIN 60 0.0022
950 BLOOD GLUCOSE INCREASED 412 0.0022
951 ADVERSE DRUG REACTION 196 0.0022
952 MEDICATION ERROR 121 0.0022
953 DRY SKIN 288 0.0022
954 HOT FLUSH 162 0.0021
955 THERAPEUTIC PRODUCT EFFECT DECREASED 95 0.0021
956 FLUSHING 214 0.0021
957 EYE IRRITATION 121 0.0021
958 AGGRESSION 105 0.0021
959 GAIT INABILITY 70 0.0021
960 THERAPY CESSATION 104 0.0020
961 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 364 0.0020
962 ACCIDENTAL OVERDOSE 72 0.0020
963 DEVICE DISLOCATION 82 0.0019
964 THERAPEUTIC RESPONSE SHORTENED 62 0.0019
965 MULTIPLE SCLEROSIS RELAPSE 119 0.0017
966 CRYING 62 0.0017
967 NIGHTMARE 56 0.0016
968 DRUG EFFECT DECREASED 86 0.0016
969 ADVERSE EVENT 145 0.0016
970 IRRITABILITY 94 0.0016
971 INJECTION SITE REACTION 107 0.0016
972 ACNE 111 0.0015
973 MULTIPLE SCLEROSIS 69 0.0014
974 DRUG ABUSE 120 0.0014
975 SKIN IRRITATION 66 0.0014
976 UNDERDOSE 98 0.0013
977 INJECTION SITE PRURITUS 89 0.0013
978 DRUG DOSE OMISSION 196 0.0012
979 INJECTION SITE BRUISING 93 0.0012
980 SKIN BURNING SENSATION 79 0.0011
981 INJECTION SITE ERYTHEMA 132 0.0011
982 DEVICE ISSUE 93 0.0010
983 INCORRECT DOSE ADMINISTERED 235 0.0010
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 70 0.0010
985 SUICIDE ATTEMPT 58 0.0010
986 INJECTION SITE PAIN 292 0.0010
987 INJECTION SITE SWELLING 72 0.0009
988 NO ADVERSE EVENT 158 0.0009
989 PRODUCT QUALITY ISSUE 112 0.0008
990 DRUG WITHDRAWAL SYNDROME 70 0.0008
991 INJECTION SITE HAEMORRHAGE 63 0.0008
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 157 0.0008
993 DRUG DEPENDENCE 122 0.0008
994 BREAST CANCER 61 0.0007